天然产物杨梅素抗卵巢癌研究进展
Research Progress of Natural Product Myricetin against Ovarian Cancer
DOI: 10.12677/ACM.2023.1371535, PDF,   
作者: 陈 琳：西安医学院研究生院，陕西 西安
关键词: 杨梅素；卵巢癌；肿瘤；作用机制；Myricetin； Ovarian Cancer； Tumor； Mechanism of Action
摘要: 卵巢癌的致死率居妇科恶性肿瘤首位，患者的远期生存率低，开发高效、低毒的新药物对于卵巢癌治疗具有重要意义。近年来，越来越多的研究发现了天然黄酮类化合物杨梅素的抗肿瘤活性，杨梅素通过诱导肿瘤细胞凋亡、抑制增殖和迁移侵袭、提高化疗敏感性等多种机制发挥抗肿瘤作用。本文就杨梅素在卵巢癌中的研究进展进行阐述，为天然产物的临床应用提供科学依据。
Abstract: Ovarian cancer is the gynecological malignant tumor with the highest fatality rate, and the long-term survival rate of patients is low. The development of new drugs with high efficiency and low toxicity is of great significance for the treatment of ovarian cancer. In recent years, more and more studies have found the anti-tumor activity of natural flavonoids myricetin, which plays an an-ti-tumor effect by inducing tumor cell apoptosis, inhibiting proliferation, inhibiting migration and invasion, improving chemotherapy sensitivity, and so on. This paper reviews the research progress of myricetin in ovarian cancer in order to provide scientific basis for the clinical application of natu-ral products.
文章引用：陈琳. 天然产物杨梅素抗卵巢癌研究进展[J]. 临床医学进展, 2023, 13(7): 10996-11001. https://doi.org/10.12677/ACM.2023.1371535

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Siegel, R.L., Miller, K.D., Wagle, N.S., et al. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
[3] Lheureux, S., Braunstein, M. and Oza, A.M. (2019) Epithelial Ovarian Cancer: Evolution of Management in the Era of Precision Medi-cine. CA: A Cancer Journal for Clinicians, 69, 280-304. [Google Scholar] [CrossRef] [PubMed]
[4] Javed, Z., Khan, K., Herrera-Bravo, J., et al. (2022) Myricetin: Targeting Signaling Networks in Cancer and Its Implication in Chemo-therapy. Cancer Cell International, 22, Article No. 239. [Google Scholar] [CrossRef] [PubMed]
[5] 杨冲, 张良, 宋晓峰, 等. 杨梅素及其衍生物研究进展[J]. 药学进展, 2019, 43(3): 217-225.
[6] Devi, K.P., Rajavel, T., Habtemariam, S., et al. (2015) Molecular Mechanisms Underlying Anticancer Effects of Myricetin. Life Sciences, 142, 19-25. [Google Scholar] [CrossRef] [PubMed]
[7] Ha, T.K., Jung, I., Kim, M.E., et al. (2017) Anti-Cancer Ac-tivity of Myricetin against Human Papillary Thyroid Cancer Cells Involves Mitochondrial Dysfunction-Mediated Apop-tosis. Biomedicine & Pharmacotherapy, 91, 378-384. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, X.H., Chen, S.Y., Tang, L., et al. (2013) Myricetin In-duces Apoptosis in HepG2 Cells through Akt/p70S6K/Bad Signaling and Mitochondrial Apoptotic Pathway. An-ti-Cancer Agents in Medicinal Chemistry, 13, 1575-1581. [Google Scholar] [CrossRef] [PubMed]
[9] Yang, C., Lim, W., Bazer, F.W., et al. (2017) Myrice-tin Suppresses Invasion and Promotes Cell Death in Human Placental Choriocarcinoma Cells through Induction of Oxi-dative Stress. Cancer Letters, 399, 10-19. [Google Scholar] [CrossRef] [PubMed]
[10] Park, H., Park, S., Bazer, F.W., et al. (2018) Myricetin Treatment Induces Apoptosis in Canine Osteosarcoma Cells by Inducing DNA Fragmentation, Disrupting Redox Homeostasis, and Mediating Loss of Mitochondrial Membrane Potential. Journal of Cellular Physiology, 233, 7457-7466. [Google Scholar] [CrossRef] [PubMed]
[11] Siegelin, M.D., Gaiser, T., Habel, A., et al. (2009) Myricetin Sensitizes Ma-lignant Glioma Cells to TRAIL-Mediated Apoptosis by Down-Regulation of the Short Isoform of FLIP and bcl-2. Can-cer Letters, 283, 230-238. [Google Scholar] [CrossRef] [PubMed]
[12] Sun, F., Zheng, X.Y., Ye, J., et al. (2012) Potential Anticancer Activity of Myricetin in Human T24 Bladder Cancer Cells both in Vitro and in Vivo. Nutrition and Cancer, 64, 599-606. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, X.H., Zou, Z.Q., Xu, C.W., et al. (2011) Myricetin Induces G2/M Phase Arrest in HepG2 Cells by Inhibiting the Activity of the Cyclin B/Cdc2 Complex. Molecular Medi-cine Reports, 4, 273-277. [Google Scholar] [CrossRef] [PubMed]
[14] Shiomi, K., Kuriyama, I., Yoshida, H., et al. (2013) Inhibitory Effects of Myricetin on Mammalian DNA Polymerase, Topoisomerase and Human Cancer Cell Proliferation. Food Chemistry, 139, 910-918. [Google Scholar] [CrossRef] [PubMed]
[15] Zhou, Z., Mao, W., Li, Y., et al. (2019) Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways. The Ana-tomical Record (Hoboken), 302, 2186-2192. [Google Scholar] [CrossRef] [PubMed]
[16] Zhu, M.L., Zhang, P.M., Jiang, M., et al. (2020) Myricetin Induces Apopto-sis and Autophagy by Inhibiting PI3K/Akt/mTOR Signalling in Human Colon Cancer Cells. BMC Complementary Med-icine and Therapies, 20, Article No. 209. [Google Scholar] [CrossRef] [PubMed]
[17] Phillips, P.A., Sangwan, V., Borja-Cacho, D., et al. (2011) Myricetin Induces Pancreatic Cancer Cell Death via the Induction of Apop-tosis and Inhibition of the Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway. Cancer Letters, 308, 181-188. [Google Scholar] [CrossRef] [PubMed]
[18] Ko, C.H., Shen, S.C., Lee, T.J., et al. (2005) Myricetin Inhibits Matrix Metalloproteinase 2 Protein Expression and Enzyme Activity in Colorectal Carcinoma Cells. Molecular Cancer Therapeutics, 4, 281-290. [Google Scholar] [CrossRef] [PubMed]
[19] Ci, Y., Zhang, Y., Liu, Y., et al. (2018) Myricetin Suppresses Breast Cancer Metastasis through Down-Regulating the Activity of Matrix Metalloproteinase (MMP)-2/9. Phytotherapy Research, 32, 1373-1381. [Google Scholar] [CrossRef] [PubMed]
[20] Jung, S.K., Lee, K.W., Kim, H.Y., et al. (2010) Myricetin Suppresses UVB-Induced Wrinkle Formation and MMP-9 Expression by Inhibiting Raf. Biochemical Pharmacology, 79, 1455-1461. [Google Scholar] [CrossRef] [PubMed]
[21] Ma, H., Zhu, L., Ren, J., et al. (2019) Myricetin Inhibits Migration and Invasion of Hepatocellular Carcinoma MHCC97H Cell Line by Inhibiting the EMT Process. Oncology Letters, 18, 6614-6620. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, L., Feng, J., Chen, X., et al. (2014) Myricetin Enhance Chemo-sensitivity of 5-Fluorouracil on Esophageal Carcinoma in Vitro and in Vivo. Cancer Cell International, 14, Article No. 71. [Google Scholar] [CrossRef] [PubMed]
[23] Biswas, R., Bugde, P., He, J., et al. (2019) Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells. Cancers (Basel), 11, Article No. 1330. [Google Scholar] [CrossRef] [PubMed]
[24] Xiao, L., Shi, X.Y., Zhang, Y., et al. (2016) YAP Induces Cisplatin Resistance through Activation of Autophagy in Human Ovarian Carcinoma Cells. OncoTargets and Therapy, 9, 1105-1114. [Google Scholar] [CrossRef] 
[25] Li, M., Chen, J., Yu, X., et al. (2019) Myricetin Suppress-es the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP. Cells, 8, Article No. 358. [Google Scholar] [CrossRef] [PubMed]
[26] Nadova, S., Miadokova, E. and Cipak, L. (2007) Flavonoids Potentiate the Efficacy of Cytarabine through Modulation of Drug-Induced Apoptosis. Neoplasma, 54, 202-206.
[27] Huang, H., Chen, A.Y., Ye, X., et al. (2015) Myricetin Inhibits Proliferation of Cisplatin-Resistant Cancer Cells through a p53-Dependent Apoptotic Pathway. International Journal of Oncology, 47, 1494-1502. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, Y., Chen, S., Wei, C., et al. (2018) Flavonoids from Chinese Bayberry Leaves Induced Apoptosis and G1 Cell Cycle Arrest via Erk Pathway in Ovarian Cancer Cells. European Journal of Medicinal Chemistry, 147, 218-226. [Google Scholar] [CrossRef] [PubMed]
[29] Abd, G.M., Othman, R. and Nordin, N. (2020) Molecular Docking Study of Naturally Derived Flavonoids with Antiapoptotic BCL-2 and BCL-XL Proteins toward Ovarian Can-cer Treatment. Journal of Pharmacy and Bioallied Sciences, 12, S676-S680. [Google Scholar] [CrossRef] 
[30] Li, Q., Tan, Q., Ma, Y., et al. (2022) Myricetin Suppresses Ovar-ian Cancer in Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress. Fron-tiers in Oncology, 12, Article ID: 903394. [Google Scholar] [CrossRef] [PubMed]
[31] Das, A., Majumder, D. and Saha, C. (2017) Correlation of Binding Efficacies of DNA to Flavonoids and Their Induced Cellular Damage. Journal of Photochemistry and Photobiology B, 170, 256-262. [Google Scholar] [CrossRef] [PubMed]
[32] Jomova, K., Hudecova, L., Lauro, P., et al. (2019) A Switch between Antioxidant and Prooxidant Properties of the Phenolic Compounds Myricetin, Morin, 3’,4’-Dihydroxyflavone, Taxifolin and 4-Hydroxy-Coumarin in the Presence of Copper(II) Ions: A Spectroscopic, Absorption Titration and DNA Damage Study. Molecules, 24, Article No. 4335. [Google Scholar] [CrossRef] [PubMed]
[33] Xu, Y., Xie, Q., Wu, S., et al. (2016) Myricetin Induces Apopto-sis via Endoplasmic Reticulum Stress and DNA Double-Strand Breaks in Human Ovarian Cancer Cells. Molecular Medicine Reports, 13, 2094-2100. [Google Scholar] [CrossRef] [PubMed]
[34] Huang, H., Chen, A.Y., Rojanasakul, Y., et al. (2015) Dietary Com-pounds Galangin and Myricetin Suppress Ovarian Cancer Cell Angiogenesis. Journal of Functional Foods, 15, 464-475. [Google Scholar] [CrossRef] [PubMed]
[35] Zheng, A.W., Chen, Y.Q., Zhao, L.Q., et al. (2017) Myricetin In-duces Apoptosis and Enhances Chemosensitivity in Ovarian Cancer Cells. Oncology Letters, 13, 4974-4978. [Google Scholar] [CrossRef] [PubMed]

为你推荐